<qa>  What is the name of the subject with untreated or symptomatic brain metastasis5. Subjects having untreated or symptomatic brain metastasis, or subjects with leptomeningeal disease. Subjects with treated metastases, who are off corticosteroids and who are neurologically stable for at least 2 months may participate in the trial. 